IDDF2023-ABS-0112 Prognostic Implication of Liver Fibrosis Scores in Patients with Non-Ischemic Dilated Cardiomyopathy

Yupeng Liu,Jingjing Song,Wenyao Wang,Yi-Da Tang

DOI: https://doi.org/10.1136/gutjnl-2023-iddf.136

2023-01-01

Abstract:Background Liver fibrosis was associated with adverse outcomes in various cardiovascular diseases. The present risk stratification of non-ischemic dilated cardiomyopathy (NIDCM) still largely depends on the left ventricular ejection fraction (LVEF), but it performed far from satisfactory. Therefore, identifying potential risk factors is of great significance for the clinical management of NIDCM. At present, the relationship between liver fibrosis and prognosis in patients with NIDCM remains blank. Methods A total of 433 NIDCM patients were analyzed in the present study. Liver fibrosis was staged by three liver fibrosis scores (LFS), including aspartate aminotransferase to platelet ratio index (APRI), aspartate aminotransferase/alanine aminotransferase ratio (AST/ALT ratio), and gamma-glutamyltransferase platelet ratio (GPR). The primary endpoint was all-cause mortality or heart transplantation (ACM/HTx). Results During a median of 1.7 years of follow-up, 140 (32.3%) ACM/HTx events were recorded. There is a positive relationship between noninvasive markers and ACM/HTx. Patients with increased APRI, AST/ALT ratio, and GPR scores exhibited increased ACM/HTx (all p<0.05, IDDF2023-ABS-0112 Figure 1). Intermediate-to-high APRI (HR 1.52, 95%CI 1.05-2.2, p=0.026), AST/ALT ratio (HR 1.55, 95%CI 1.08-2.24, p=0.019), and GPR (HR 1.59, 95%CI 1.01-2.5, p=0.047), were associated with increased risk of ACM/HTx compare to low score groups, independent of LVEF and other covariables. The positive relationship remains the same in different subgroups, including those with diabetes and obesity. Conclusions Elevated LFSs were associated with a worse outcome beyond LVEF in patients with NIDCM, which may provide additional prognostic value in dilated cardiomyopathy.